Author: ["Ling Qi","Margaret A. Strong","Baktiar O. Karim","David L. Huso","Carol W. Greider"]
CITE.CC academic search helps you expand the influence of your papers.
Abstract
Telomeres protect chromosome ends from fusion, degradation and recombination. Loss of telomere function has opposite effects on tumorigenesis: apoptosis, which inhibits tumour growth, and genomic instability, which accelerates tumour formation. Here we describe a new mechanism by which short telomeres inhibit tumorigenesis through interference with oncogenic translocations. In mice that are null for both ataxia-telangiectasia-mutated (Atm) and telomerase RNA (mTR), the first generation (G1) Atm−/− mTR−/− mice have a lower rate of tumour formation than Atm−/− mTR+/+ mice. These Atm−/− mTR−/− G1 tumours show no increase in either apoptosis or overall genomic instability. Strikingly, the tumours show a high fraction of translocations containing telomere signals at the translocation junctions. Translocations of the T-cell receptors on chromosome 14, which initiate tumorigenesis, were interrupted by fusion with telomeres. Telomere repeats were also detected at the translocation junctions in pre-malignant thymocytes. We propose that telomere fusion to DNA double-strand breaks competes with the generation of oncogenic translocations and thus reduces tumour formation.
Cite this article
Qi, L., Strong, M., Karim, B. et al. Telomere fusion to chromosome breaks reduces oncogenic translocations and tumour formation. Nat Cell Biol 7, 706–711 (2005). https://doi.org/10.1038/ncb1276